NIH-funded research Career grant

Understanding how the central amygdala affects withdrawal from oxycodone

Official title: Functional and molecular characterization of the central amygdala in the context of oxycodone withdrawal

Funded at Washington University · NIH-11053470 · Data updated 2026-11-12

This study looks at how a part of the brain called the central amygdala affects people trying to stop using oxycodone, an opioid, by exploring how certain brain cells behave during withdrawal, which could help improve treatment for those dealing with opioid dependence.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startMay 1, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$165,911
NIH project number5K99DA056691-02
Project IDNIH-11053470 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced withdrawal symptoms from oxycodone or other opioids.

Less likely to help

Patients who have never used opioids or those who are not experiencing withdrawal symptoms may not benefit from this research.

What this research studies

This research investigates the role of the central amygdala in the withdrawal process from oxycodone, a commonly prescribed opioid. By examining specific neuronal subpopulations within this brain region, the study aims to identify how these cells contribute to withdrawal symptoms and the potential for relapse into drug use. The approach includes using rodent models to observe changes in behavior and neuronal activity during withdrawal. This research could lead to better treatment strategies for individuals struggling with opioid dependence.

Why it matters

Potential benefit: If successful, this research could lead to improved therapies for managing opioid withdrawal and reducing the risk of relapse.

How similar studies have gone: Previous research has shown that targeting specific brain regions can influence withdrawal behaviors, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Slivicki, Richard — Washington University
  • Study coordinator: Slivicki, Richard

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.